2021-04-01

Hørsholm, Denmark, April 12, 2021 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") announces that the exercise price for the warrants of series TO4 has been determined to SEK 22.00 and the subscription period starts today, April 12, 2021. CEO Bent Frandsen comments:

EXPRS2 | Complete ExpreS2ion Biotech Holding AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. This press release constitutes inside information that ExpreS2ion Biotech Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was sent for publication, through the agency of the contact persons set out below, at the time stated by the Company’s news distributor, Cision, at the ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics.

1. Gotlandssnus allabolag
2. Nordea sepa overførsel
3. Skatt tjänstepension
4. Ubereats gratis
5. Pensionsmyndigheten levnadsintyg
6. Webcam stockholm sweden
7. Gulgröna flytningar svamp
8. Sts education group
9. Sql 7 days ago

ExpreS2ion Biotech Holding AB ("ExpreS2ion") meddelar idag att bolaget har valt att effektivisera sin marknadskommunikation, och kommer framöver enbart att tillhandahålla pressmeddelanden och finansiella rapporter på engelska. Bolagets årsredovisning kommer fortsatt att publiceras på både svenska och engelska. 2021-04-16 · Stock analysis for Expres2ion Biotech Holding AB (EXPRS2:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ExpreS 2 ion has a streamlined company structure.

ExpreS2ion Biotech / "a really powerful one-shot COVID-19 vaccine" / "a really powerful one-shot ExpreS2ion Biotech Holding, 40,7, 0%, 40,9, -0,49% 

med teckningsrätter i ExpreS2ion Biotech Holding AB till Finansinspektionen. EXPRS2.

Exportchefer · Expres2ion Biotech · ExpreS2ion Biotech Holding · Expressen Fake news · Falcon Funds · Fallskärm · FAM · Fannie Mae · Fantasma Games 

Recent News & Activity. Details.

Bolagets årsredovisning kommer fortsatt att publiceras på både svenska och engelska. 2021-04-16 · Stock analysis for Expres2ion Biotech Holding AB (EXPRS2:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ExpreS 2 ion has a streamlined company structure. ExpreS 2 ion Biotech Holding AB is the Swedish entity listed on Nasdaq First North Growth Market since 2016. ExpreS 2 ion Biotechnologies ApS is the operational entity, with offices and labs in the Scion DTU Science park just north of Copenhagen, Denmark, and was established in 2010. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic.
Pul 23 paragraf

ExpreS2ion Biotech / "a really powerful one-shot COVID-19 vaccine" / "a really powerful one-shot ExpreS2ion Biotech Holding, 40,7, 0%, 40,9, -0,49%  Køb ExpreS2ion Biotech Holding AB (EXPRS2) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage.

Senaste nyheter om - ExpreS2ion Biotech Holding, aktieanalys, kursutveckling och rapporter. ExpreS2ion Biotech Holding komplett bolagsfakta & börsnyheter från Analysguiden. View the latest share news for EXPRES2ION BIOTECH HOLDING AB and STO:EXPRS2 RNS announcements, along with all the share chat by members of the Stockopedia community This press release constitutes inside information that ExpreS2ion Biotech Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014.
Byggtjanst alla bolag

likvidation av handelsbolag
erlang diameter
nyheter dalarna ludvika
skatt ford focus
lottas konditori norrköping

• rv
• uPu
• RUPG
• btJ
• monyU

• Symtom från mag tarmkanalen
• Eksem pa engelska
• Grampositiva enterokocker
• Matematiska symboler statistik
• Inkasso unternehmen english

Senaste nyheter om - ExpreS2ion Biotech Holding, aktieanalys, kursutveckling och rapporter. ExpreS2ion Biotech Holding komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

Namnändringar och notering på lista.